melphalan
Sign in to saveMelphalan, sold under the brand name Alkeran among others, is a chemotherapy medication used to treat multiple myeloma; malignant lymphoma; lymphoblastic and myeloblastic leukemia; childhood neuroblastoma; ovarian cancer; mammary adenocarcinoma; and uveal melanoma. It is taken by mouth or by injection into a vein.
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 462248349
- Drug.image
- Melphalan.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 240
- Drug.image2
- Melphalan ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Alkeran, Evomela, Hepzato, Ivra, Phelinun, others
- Drug.MedlinePlus
- a682220
- Drug.DailyMedID
- Melphalan
- Drug.routes_of_administration
- By mouth, intravenous, intra-arterial
- Drug.ATC_prefix
- L01
- Drug.ATC_suffix
- AA03
- Drug.legal_AU
- S4
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.bioavailability
- 25–89% (By mouth)
- Drug.metabolism
- Hydrolysis to inactive metabolites
via Wikipedia infobox
Article
9 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Pharmacokinetics
- Mechanism of action
- Synthesis
- Society and culture
- Legal status
- References
{{Infobox drug | Watchedfields = changed | verifiedrevid = 462248349 | image = Melphalan.svg | image_class = skin-invert-image | width = 240 | alt = | image2 = Melphalan ball-and-stick.png | image_class2 = bg-transparent | alt2 =
| pronounce = | tradename = Alkeran, Evomela, Hepzato, Ivra, Phelinun, others | Drugs.com = | MedlinePlus = a682220 | DailyMedID = Melphalan | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, intravenous, intra-arterial | class = | ATC_prefix = L01 | ATC_suffix = AA03 | ATC_supplemental =